Pharma Journalist 9038 posts 0 comments

Atreca, Inc. BeiGene, Ltd. and IGM Biosciences, Inc. announced their plans to collaborate to help address the COVID-19 pandemic. The companies will leverage their combined technology…
Read More...

GlaxoSmithKline plc announced the US Food and Drug Administration (FDA) approved the company’s supplemental New Drug Application (sNDA) for Zejula (niraparib), an oral, once-daily poly…
Read More...

Catalent, Inc. announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent’s Biologics business unit will accelerate availability of…
Read More...

London – On Tuesday, (12th May) CTS Virtual (https://arena-international.com/ctsvirtual/),  will host new key sessions on Clinical Trial Supply 2020 Trends, Stem-gene Clinical Trials…
Read More...

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced by Quotient Sciences and CytoAgents, Inc. The partnership will…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved an additional recommended dosage of 400 mg every six…
Read More...

Q2Earth, Inc. announced that its wholly-owned subsidiary, QSAM Therapeutics Inc. has signed a Patent and Technology License Agreement and Trademark Assignment with IGL Pharma, Inc.…
Read More...

Pneumagen Ltd, a University of St Andrews spinout, focused on treating infectious disease and oncology by targeting the human glycome, today announced results from three separate in…
Read More...

Kamada Ltd. and Kedrion Biopharma, two prominent bio-pharmaceutical companies specialized in plasma-derived protein therapeutics, announced a global collaboration for the development,…
Read More...

In response to the novel coronavirus (SARS-CoV-2), Shionogi & Co., Ltd. (hereafter “Shionogi”), a pharmaceutical company with a major focus on infectious diseases, has joined the…
Read More...